ABCG2: the key to chemoresistance in cancer stem cells?

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.12, 2009-12, pp. : 1529-1542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Stem Cells in Prostate Cancer Chemoresistance

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 225-240

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer

Current Cancer Drug Targets, Vol. 16, Iss. 9, 2016-10 ,pp. : 738-754

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting cancer stem cells

By Kvinlaug Brynn T Huntly Brian JP

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 915-927

Informa Healthcare

Access to resources Recommend Favorite

Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 40-53

Bentham Science Publishers

Access to resources Recommend Favorite